Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $7.3500 (0.27%) ($7.3500 - $7.3500) on Mon. Feb. 1, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.65% (three month average) | RSI | 27 | Latest Price | $7.3500(0.27%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -3.8% a day on average for past five trading days. | Weekly Trend | AUTL declines -6.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) LIT(13%) SKYY(13%) XBI(13%) BNDX(12%) IBB(12%) | Factors Impacting AUTL price | AUTL will decline at least -2.325% in a week (0% probabilities). USO(-7%) TBT(-7%) VIXM(-6%) IGOV(-6%) UNG(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.325% (StdDev 4.65%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-4.24(-157.69%) | Inflection Point | Yes | Resistance Level | $8.66 | 5 Day Moving Average | $7.88(-6.73%) | 10 Day Moving Average | $8.3(-11.45%) | 20 Day Moving Average | $8.66(-15.13%) | To recent high | -38.8% | To recent low | 0.3% | Market Cap | $384m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |